WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
ABIO
ARCA BIOPHARMA INC
$47.29MN/A0.00%N/AN/AN/AN/A
DNTH
DIANTHUS THERAPEUTICS INC
$704.62MN/A0.00%N/AN/AN/AN/A
NEO
NEOGENOMICS INC
$1.88BN/A0.00%N/AN/AN/AN/A
LRMR
LARIMAR THERAPEUTICS INC
$485.52MN/A0.00%N/AN/AN/AN/A
ICAD
ICAD INC
$39.54MN/A0.00%N/AN/AN/AN/A
CLPT
CLEARPOINT NEURO INC
$148.91MN/A0.00%N/AN/AN/AN/A
SRTS
SENSUS HEALTHCARE INC
$63.28MN/A0.00%N/AN/AN/AN/A
TRVI
TREVI THERAPEUTICS INC
$207.57MN/A0.00%N/AN/AN/AN/A
BPMC
BLUEPRINT MEDICINES CORP
$6.70BN/A0.00%N/AN/AN/AN/A
LSTA
LISATA THERAPEUTICS INC
$24.34MN/A0.00%N/AN/AN/AN/A
IOBT
IO BIOTECH INC
$100.80MN/A0.00%N/AN/AN/AN/A
LFMD
LIFEMD INC
$504.17MN/A0.00%N/AN/AN/AN/A
TCRX
TSCAN THERAPEUTICS INC
$414.18MN/A0.00%N/AN/AN/AN/A
TNDM
TANDEM DIABETES CARE INC
$2.36BN/A0.00%N/AN/AN/AN/A
LABP
LANDOS BIOPHARMA INC
$69.35MN/A0.00%N/AN/AN/AN/A
NVNO
ENVVENO MEDICAL CORP
$67.38MN/A0.00%N/AN/AN/AN/A
CLDX
CELLDEX THERAPEUTICS INC
$2.28BN/A0.00%N/AN/AN/AN/A
AUGX
AUGMEDIX INC
$129.65MN/A0.00%N/AN/AN/AN/A
BOLT
BOLT BIOTHERAPEUTICS INC
$41.94MN/A0.00%N/AN/AN/AN/A
NURO
NEUROMETRIX INC
$8.88MN/A0.00%N/AN/AN/AN/A
PMCB
PHARMACYTE BIOTECH INC
$18.28MN/A0.00%N/AN/AN/AN/A
TELA
TELA BIO INC
$114.13MN/A0.00%N/AN/AN/AN/A
STIM
NEURONETICS INC
$104.15MN/A0.00%N/AN/AN/AN/A
ATXS
ASTRIA THERAPEUTICS INC
$513.34MN/A0.00%N/AN/AN/AN/A
AVXL
ANAVEX LIFE SCIENCES CORP
$308.74MN/A0.00%N/AN/AN/AN/A
HOWL
WEREWOLF THERAPEUTICS INC
$259.84MN/A0.00%N/AN/AN/AN/A
RIGL
RIGEL PHARMACEUTICALS INC
$201.68MN/A0.00%N/AN/AN/AN/A
TERN
TERNS PHARMACEUTICALS INC
$342.01MN/A0.00%N/AN/AN/AN/A
ATOS
ATOSSA THERAPEUTICS INC
$190.46MN/A0.00%N/AN/AN/AN/A
VTRS
VIATRIS INC
$13.78B2.07%960.00%$0.1200$0.2441%0
EVGN
EVOGENE LTD
$35.71MN/A0.00%N/AN/AN/AN/A
SRDX
SURMODICS INC
$492.68MN/A0.00%N/AN/AN/AN/A
ELVN
ENLIVEN THERAPEUTICS INC
$867.89MN/A0.00%N/AN/AN/AN/A
PROF
PROFOUND MEDICAL CORP
$157.07MN/A0.00%N/AN/AN/AN/A
DNA
GINKGO BIOWORKS HOLDINGS INC
$1.85BN/A0.00%N/AN/AN/AN/A
SDGR
SCHRODINGER INC
$1.69BN/A0.00%N/AN/AN/AN/A
DMTK
DERMTECH INC
$21.78MN/A0.00%N/AN/AN/AN/A
CABA
CABALETTA BIO INC
$607.84MN/A0.00%N/AN/AN/AN/A
DMAC
DIAMEDICA THERAPEUTICS INC
$99.83MN/A0.00%N/AN/AN/AN/A
ETNB
89BIO INC
$828.42MN/A0.00%N/AN/AN/AN/A
TTNP
TITAN PHARMACEUTICALS INC
$6.13MN/A0.00%N/AN/AN/AN/A
SNSE
SENSEI BIOTHERAPEUTICS INC
$41.37MN/A0.00%N/AN/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$57.14MN/A0.00%N/AN/AN/AN/A
AKRO
AKERO THERAPEUTICS INC
$1.11BN/A0.00%N/AN/AN/AN/A
FDMT
4D MOLECULAR THERAPEUTICS INC
$1.31BN/A0.00%N/AN/AN/AN/A
TBPH
THERAVANCE BIOPHARMA INC
$451.30MN/A0.00%N/AN/AN/AN/A
PULM
PULMATRIX INC
$7.41MN/A0.00%N/AN/AN/AN/A
RXRX
RECURSION PHARMACEUTICALS INC
$2.06BN/A0.00%N/AN/AN/AN/A
CMAX
CAREMAX INC
$13.12MN/A0.00%N/AN/AN/AN/A
URGN
UROGEN PHARMA LTD
$486.58MN/A0.00%N/AN/AN/AN/A
OCGN
OCUGEN INC
$339.67MN/A0.00%N/AN/AN/AN/A
OPTN
OPTINOSE INC
$98.91MN/A0.00%N/AN/AN/AN/A
PACS
PACS GROUP INC
N/AN/A0.00%N/AN/AN/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.53BN/A0.00%N/AN/AN/AN/A
MNKD
MANNKIND CORP
$1.18BN/A0.00%N/AN/AN/AN/A
PHAR
PHARMING GROUP NV
$671.07MN/A0.00%N/AN/AN/AN/A
OCUL
OCULAR THERAPEUTIX INC
$872.44MN/A0.00%N/AN/AN/AN/A
ICCM
ICECURE MEDICAL LTD
$53.96MN/A0.00%N/AN/AN/AN/A
QIPT
QUIPT HOME MEDICAL CORP
$168.83MN/A0.00%N/AN/AN/AN/A
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
$425.12MN/A0.00%N/AN/AN/AN/A
GTHX
G1 THERAPEUTICS INC
$232.13MN/A0.00%N/AN/AN/AN/A
ECOR
ELECTROCORE INC
$36.74MN/A0.00%N/AN/AN/AN/A
AKYA
AKOYA BIOSCIENCES INC
$196.07MN/A0.00%N/AN/AN/AN/A
FOLD
AMICUS THERAPEUTICS INC
$3.08BN/A0.00%N/AN/AN/AN/A
BYSI
BEYONDSPRING INC
$84.30MN/A0.00%N/AN/AN/AN/A
EXAS
EXACT SCIENCES CORP
$10.99BN/A0.00%N/AN/AN/AN/A
NARI
INARI MEDICAL INC
$2.44BN/A0.00%N/AN/AN/AN/A
RDNT
RADNET INC
$3.54BN/A0.00%N/AN/AN/AN/A
PSTX
POSEIDA THERAPEUTICS INC
$269.20MN/A0.00%N/AN/AN/AN/A
TCRT
ALAUNOS THERAPEUTICS INC
$21.78MN/A0.00%N/AN/AN/AN/A
BGLC
BIONEXUS GENE LAB CORP
$10.78MN/A0.00%N/AN/AN/AN/A
RPTX
REPARE THERAPEUTICS INC
$141.31MN/A0.00%N/AN/AN/AN/A
TARS
TARSUS PHARMACEUTICALS INC
$1.19BN/A0.00%N/AN/AN/AN/A
SYRA
SYRA HEALTH CORP
$16.88MN/A0.00%N/AN/AN/AN/A
BLFS
BIOLIFE SOLUTIONS INC
$822.65MN/A0.00%N/AN/AN/AN/A
BFLY
BUTTERFLY NETWORK INC
$194.27MN/A0.00%N/AN/AN/AN/A
PNTG
PENNANT GROUP INC
$636.27MN/A0.00%N/AN/AN/AN/A
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$2.21BN/A0.00%N/AN/AN/AN/A
IPHA
INNATE PHARMA SA
$195.50MN/A0.00%N/AN/AN/AN/A
LNSR
LENSAR INC
$35.55MN/A0.00%N/AN/AN/AN/A
CLLS
CELLECTIS SA
$214.54MN/A0.00%N/AN/AN/AN/A
BRTX
BIORESTORATIVE THERAPIES INC
$9.88MN/A0.00%N/AN/AN/AN/A
LEXX
LEXARIA BIOSCIENCE CORP
$38.66MN/A0.00%N/AN/AN/AN/A
SILO
SILO PHARMA INC
$5.26MN/A0.00%N/AN/AN/AN/A
TLPH
TALPHERA INC
$17.31MN/A0.00%N/AN/AN/AN/A
INVA
INNOVIVA INC
$971.80MN/A0.00%$0.2500N/AN/A0
IMRN
IMMURON LTD
$14.47MN/A0.00%N/AN/AN/AN/A
HOOK
HOOKIPA PHARMA INC
$90.84MN/A0.00%N/AN/AN/AN/A
ZJYL
JIN MEDICAL INTERNATIONAL LTD
$563.20MN/A0.00%N/AN/AN/AN/A
EVH
EVOLENT HEALTH INC
$3.16BN/A0.00%N/AN/AN/AN/A
AADI
AADI BIOSCIENCE INC
$49.60MN/A0.00%N/AN/AN/AN/A
CANF
CAN-FITE BIOPHARMA LTD
$8.28MN/A0.00%N/AN/AN/AN/A
BNR
BURNING ROCK BIOTECH LTD
$77.75MN/A0.00%N/AN/AN/AN/A
SWTX
SPRINGWORKS THERAPEUTICS INC
$3.21BN/A0.00%N/AN/AN/AN/A
CRVO
CERVOMED INC
$148.96MN/A0.00%N/AN/AN/AN/A
OCX
ONCOCYTE CORP
$22.99MN/A0.00%N/AN/AN/AN/A
BLRX
BIOLINERX LTD
$48.05MN/A0.00%N/AN/AN/AN/A
AMWL
AMERICAN WELL CORP
$154.16MN/A0.00%N/AN/AN/AN/A
STOK
STOKE THERAPEUTICS INC
$541.29MN/A0.00%N/AN/AN/AN/A
EKSO
EKSO BIONICS HOLDINGS INC
$23.45MN/A0.00%N/AN/AN/AN/A
1...456...12

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
681+1.42%+6.14%-3.49%-18.37%7.63x5.99x+15.18%+2.53%-35.33%+82.13%Strong Buy
66-0.30%+0.61%-4.87%-1.02%38.60x4.16x-23.26%+6.41%+11.02%+11.32%Buy
17-1.19%+2.40%-1.41%+12.84%150.35x6.19x+34.83%+8.28%+14.44%+14.49%Buy
90+1.59%+5.32%+1.77%-3.85%32.91x2.15x+12.03%+3.10%+5.63%+32.23%Strong Buy
12+0.29%-1.86%+0.23%-1.13%19.75x2.90x+19.68%+6.05%+14.12%+17.07%Buy
61+0.54%+1.75%-4.53%-22.22%76.01x3.21x+6.57%+2.11%+5.20%+35.77%Buy
51-0.21%+1.36%-4.24%+7.14%-7.58x4.35x-93.45%+6.66%+13.90%+18.12%Buy
154+1.23%+3.00%-0.85%-12.65%28.83x3.68x+10.48%+5.30%+7.76%+20.08%Buy
9-0.42%-2.84%-3.75%+31.13%26.33x108.21x-8.56%+3.45%+18.82%+9.17%Buy
56-0.01%+2.38%-0.51%-11.81%56.28x3.55x+11.50%+7.83%+10.34%+20.39%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -21.7% over the past year, underperforming other healthcare stocks by -13 percentage points.

Cross Country Healthcare has an average 1 year price target of $20.40, an upside of 21.86% from Cross Country Healthcare's current stock price of $16.74.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Cross Country Healthcare, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.71% over the past year, overperforming other healthcare stocks by 8 percentage points.

3. Progyny (NASDAQ:PGNY)


Progyny (NASDAQ:PGNY) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -3.46% over the past year, overperforming other healthcare stocks by 5 percentage points.

Progyny has an average 1 year price target of $47.00, an upside of 46.55% from Progyny's current stock price of $32.07.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Progyny, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 54 percentage points higher than the healthcare sector average of 2.81%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.12%, which is 8 percentage points higher than the healthcare sector average of 2.81%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.65%, which is 6 percentage points higher than the healthcare sector average of 2.81%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.54% in the last day, and up 2.82% over the last week. Emergent Biosolutions was the among the top gainers in the healthcare sector, gaining 70.98% yesterday.

Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -48.68% in the past year. It has underperformed other stocks in the healthcare sector by -40 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -41.18% in the past year. It has underperformed other stocks in the healthcare sector by -33 percentage points.

3. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -0.71% in the past year. It has overperformed other stocks in the healthcare sector by 8 percentage points.

Are healthcare stocks a good buy now?

47.75% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 36.8% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 70.14x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.